Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov;25(11):3410-3414.
doi: 10.1111/dom.15203. Epub 2023 Jul 10.

Effect of sotagliflozin on albuminuria in patients with type 2 diabetes and chronic kidney disease

David Z I Cherney  1 , Deepak L Bhatt  2 , Michael Szarek  3 , Franklin Sun  4 , Manon Girard  4 , Michael J Davies  4 , Bertram Pitt  5 , Ph Gabriel Steg  6 ; SCORED Investigators
Affiliations
Free article

Effect of sotagliflozin on albuminuria in patients with type 2 diabetes and chronic kidney disease

David Z I Cherney et al. Diabetes Obes Metab. 2023 Nov.
Free article
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Bhatt DL, Szarek M, Pitt B, et al. Sotagliflozin in patients with diabetes and chronic kidney disease. N Engl J Med. 2021;384(2):129-139.
    1. Perkovic V, de Zeeuw D, Mahaffey KW, et al. Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS program randomised clinical trials. Lancet Diabetes Endocrinol. 2018;6(9):691-704.
    1. Oshima M, Neuen BL, Li J, et al. Early change in albuminuria with canagliflozin predicts kidney and cardiovascular outcomes: a post hoc analysis from the CREDENCE trial. J Am Soc Nephrol. 2020;31(12):2925-2936.
    1. Song P, Huang W, Onishi A, et al. Knockout of Na+-glucose cotransporter SGLT1 mitigates diabetes-induced upregulation of nitric oxide synthase NOS1 in the macula densa and glomerular hyperfiltration. Am J Physiol Renal Physiol. 2019;317:F207-F217.
    1. The Nuffield Department of Population Health Renal Studies Group, the SGLT2 Meta-Analysis Cardio-Renal Trialists' Consortium. Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials. Lancet. 2022;400(10365):1788-1801.

Publication types

MeSH terms

Substances

Grants and funding